BJH - volume 15, issue 3, may 2024
C. Maquet MD, B. De Prijck MD, A. Jaspers MD, PhD, F. Tassin MD, PhD, A. Keutgens MD, PhD, Y. Beguin MD, PhD, A. De Voeght MD
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare aggressive haematological disease with a grim prognosis. The majority of patients at diagnosis are elderly (typical age range: 60 to 70 years) and seldom fit enough to receive intensive induction therapy. We report here the case of a 76-year-old patient with significant cardiac comorbidity at the time of the diagnosis of BPDCN with bone marrow involvement. He achieved haematologic complete remission with venetoclax as first-line therapy with preservation of a good quality of life, an almost exclusively outpatient care and transfusion independency. The only adverse event was a grade 4 neutropenia without any infectious complication.
(BELG J HEMATOL 2024;15(3):125–9)
Read moreBJH - 2019, issue ?, february 2019
O. Wéra , L. Servais , C. Delierneux , A. Hego , C. Lecut , P. Delvenne , A. Nchimi , P. Lancellotti , C. Oury
BJH - volume 8, issue Abstract Book BHS, february 2017
A. Ladang , M. Simul , J. Somja MD, PhD, J. Foguenne , A. Gothot MD, PhD, A. Keutgens MD, PhD, F. Tassin MD, PhD
BJH - volume 8, issue Abstract Book BHS, february 2017
C. Gosset , J. Foguenne , M. Simul , A. Keutgens MD, PhD, F. Tassin MD, PhD, A. Gothot MD, PhD
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
